TGM5


Summary: This gene encodes a member of the transglutaminase family. The encoded protein catalyzes formation of protein cross-links between glutamine and lysine residues, often resulting in stabilization of protein assemblies. This reaction is calcium dependent. Mutations in this gene have been associated with acral peeling skin syndrome. [provided by RefSeq, Oct 2009].

NameOMIM IDEnsembl IDHGNC IDPHARMGKB IDMap Location
transglutaminase 5MIM:603805Ensembl:ENSG00000104055HGNC:HGNC:11781PA3649415q15.2

Gene Categories:

DRUGGABLE GENOME

GO terms in TGM5


Term TypeEvidence TypeGO Term IDGO Des.
BPTASGO:0006464cellular protein modification process
BPTASGO:0008544epidermis development
BPIEAGO:0018149peptide cross-linking
BPTASGO:0070268cornification
CCIEAGO:0005737cytoplasm
CCTASGO:0005886plasma membrane
MFTASGO:0003810protein-glutamine gamma-glutamyltransferase activity
MFIEAGO:0046872metal ion binding

Gene expression in normal tissue: TGM5

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in TGM5


DatabasePathway IDPathway Des.
reactomeR-HSA-1266738Developmental Biology
reactomeR-HSA-6805567Keratinization
reactomeR-HSA-6809371Formation of the cornified envelope

Gene-Drug: Aster Plot


Drug IDDrug NameModel Num.
iGMDRD353PD03259011

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in TGM5

​​​​